Effect of bydroxyethyl starch with different degrees of substitution on expression of platelet membrane glycoprotein

CHEN Gang,YAO Yuan-yuan,LIU Zi-ming
DOI: https://doi.org/10.3760/j.issn:0254-1416.2006.10.010
2006-01-01
Abstract:Objective To investigate the effect of hydroxyethyl starch (HES) with different degrees of substitution on coagulation of platelets.Methods Sixty ASA classⅠpatients of both sexes (26 males, 34 females) aged 25-45 yrs weighing 51-70 kg undergoing elective minor surgery were randomized to receive lactated Ringer's solution (LR group) or HES 200/0.5 (HES group) or HES 130/0.4 (Voluven group) 20 ml·kg-1 after induction of anesthesia ( n = 20 each) . Venous blood samples were taken before surgery (T1, baseline) , at 15 min (T2) and 6 h (T3) after LR or HES infusion for determination of the expression of platelet membrane glycoprotein (GP), CD42b, CD61/41, CD62p by flow cytometry. Results There was no significant change in the expression of GP on the resting platelet after infusion of LR or HES in all patients. The expression of CD42b, CD61/41 and CD62p on the platelet activated by ADP was significantly decreased at 15 min after HES infusion as compared to the baseline at T1 in both HES and Voluven groups (P < 0.05 or 0.01) . The expression of CD42b, CD61/41 and CD62p was still significantly lower at 6 h after HES infusion than the baseline values in HES group (P< 0.01) while in Voluven group the expression of GP returned to the preoperative baseline level. Conclusion HES 200/0.5 and to a lesser degree HES 130/0.4 can both inhibit coagulation of platelet. Fluid therapy with HES 130/0.4 can decrease the risk of hemorrhage in postoperative period.
What problem does this paper attempt to address?